Pure Global

COVID KAVACH Anti-SARS CoV-2 Human IgG ELISA kit - India CDSCO Medical Device Registration

COVID KAVACH Anti-SARS CoV-2 Human IgG ELISA kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000053_a4006d7046ff688868b76397ce73738f_88bdd13b3e93cb3fe7f875af6101f090. This device is marketed under the brand name Immunoreactive Tripsinogen. The license holder is Trivitron Healthcare Pvt. Ltd, and it is classified as Device Class Class C. The approving authority is Central Drug Standard Control Organisation, South Zone.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
COVID KAVACH Anti-SARS CoV-2 Human IgG ELISA kit
UID: MFG/IVD/2020/000053_a4006d7046ff688868b76397ce73738f_88bdd13b3e93cb3fe7f875af6101f090

Brand Name

Immunoreactive Tripsinogen

Device Class

Class C

Approving Authority

Central Drug Standard Control Organisation, South Zone

Product Information

COVID KAVACH Anti-SARS CoV-2 Human IgG ELISA kit for in vitro diagnostics, A sensitive enzyme linked immunosorbent assay for the qualitative detection of IgG antibodies to novel Covid โ€“ 19 (Immunoreactive Tripsinogen) in Human Serum or Plasma samples to identify e infected units of blood and for clinical diagnostic testing

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing